Liquid chromatography-tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-09-01
著者
-
Schellens J
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Beijnen J
Department Of Pharmacy & Pharmacology The Netherlands Cancer Institute/slotervaart Hospital
-
Beijnen Jos
Slotervaart Hospital Department Of Pharmacy And Pharmacology
-
Sparidans R
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
BEIJNEN Jos
University of Utrecht, Department of Pharmaceutical Analysis
-
LAGAS Jurjen
The Netherlands Cancer Institute, Departments of Medical Oncology and Experimental Therapy
-
Lagas Jurjen
The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
-
Schinkel Afred
The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
-
SPARIDANS Rolf
Universiteit Utrecht, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedic
-
SCHELLENS Jan
Universiteit Utrecht, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedic
-
Beijnen Jos
University Of Utrecht Department Of Pharmaceutical Analysis
関連論文
- Quantitative and selective assay of 5-methylindirubine, an inhibitor of cyclin-dependent kinases, in murine plasma using coupled liquid chromatography and electrospray tandem mass spectrometry
- Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4'-hydrazino-2-stilbazole
- Degradation kinetics of aplidine, a new marine antitumoural cyclic peptide, in aqueous solution
- A Systematic Study on the Chemical Stability of Mitomycin A and Mitomycin B
- Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography-tandem mass spectrometry
- Enzymatic digestion as a tool for the LC-MS/MS quantification of large peptides in biological matrices : Measurement of chymotryptic fragments from the HIV-1 fusion inhibitor enfuvirtide and its metabolite M-20 in human plasma
- Simultaneous quantification of cyclophosphamide and its active metabolite 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC-MS/MS)
- Simple and rapid method for the simultaneous determination of the non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma using liquid chromatography
- High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma
- Sensitive gas chromatographic determination of the cyclophosphamide metabolite 2-dechloroethylcyclophosphamide in human plasma
- Simple and selective determination of the cyclophosphamide metabolite phosphoramide mustard in human plasma using high-performance liquid chromatography
- Determination of N,N',N"-triethylenethiophosphoramide and its active metabolite N,N',N"-triethylenephosphoramide in plasma and urine using capillary gas chromatography
- High-performance liquid chromatographic determination of stabilized 4-hydroxyifosfamide in human plasma and erythrocytes
- Simultaneous determination of N,N',N''-triethylenethiophosphoramide, cyclophosphamide and some of their metabolites in plasma using capillary gas chromatography
- Determination of N,N',N''-triethylenthiophosphoramide in biological samples using capillary gas chromatography
- Liquid chromatography-tandem mass spectrometric assays for salinomycin in mouse plasma, liver brain and small intestinal contents and in OptiMEM cell culture medium
- Liquid chromatography-tandem mass spectrometric assay for the analysis of uracil, 5,6-dihydrouracil and β-ureidopropionic acid in urine for the measurement of the activities of the pyrimidine catabolic enzymes
- Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehyde
- Bioanalysis and preliminary pharmacokinetics of the acridonecarboxamide derivative GF120918 in plasma of mice and humans by ion-pairing reversed-phase high-performance liquid chromatography with fluorescence detection
- Bioanalysis of thiocoraline, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography and fluorescence detection
- Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods
- Review on the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its phase I and phase II metabolites in biological matrices, foodstuff and beverages
- Liquid chromatography-tandem mass spectrometric assay for pravastatin and two isomeric metabolites in mouse plasma and tissue homogenates
- Validation of a quantitative assay for human neutrophil peptide-1, -2, and -3 in human plasma and serum by liquid chromatography coupled to tandem mass spectrometry
- Development and validation of a liquid chromatography-tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma
- Liquid chromatography-tandem mass spectrometric assay for clobetasol propionate in human serum from patients with atopic dermatitis
- Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry
- Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma
- A validated assay for the quantitative analysis of vatalanib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry
- Liquid chromatography-tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite
- Liquid chromatography-tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma
- Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry
- A sensitive assay for the quantitative analysis of vinorelbine in mouse and human EDTA plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry
- Semi-automatic liquid chromatographic analysis of pamidronate in urine after derivatization with 1-naphthylisothiocyanate
- Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography-tandem mass spectrometry
- The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry
- A sensitive LC-MS/MS method for the quantitative analysis of the Echinacea purpurea constituent undeca-2-ene-8,10-diynoic acid isobutylamide in human plasma